This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, R. M.
Right arrow Articles by Caldecott, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. M.
Right arrow Articles by Caldecott, K. W.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2002, p. 2556-2563, Vol. 22, No. 8
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.8.2556-2563.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Central Role for the XRCC1 BRCT I Domain in Mammalian DNA Single-Strand Break Repair

Richard M. Taylor, Angela Thistlethwaite, and Keith W. Caldecott*

School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom

Received 30 October 2001/ Returned for modification 28 December 2001/ Accepted 16 January 2001

The DNA single-strand break repair (SSBR) protein XRCC1 is required for genetic stability and for embryonic viability. XRCC1 possesses two BRCA1 carboxyl-terminal (BRCT) protein interaction domains, denoted BRCT I and II. BRCT II is required for SSBR during G1 but is dispensable for this process during S/G2 and consequently for cell survival following DNA alkylation. Little is known about BRCT I, but this domain has attracted considerable interest because it is the site of a genetic polymorphism that epidemiological studies have associated with altered cancer risk. We report that the BRCT I domain comprises the evolutionarily conserved core of XRCC1 and that this domain is required for efficient SSBR during both G1 and S/G2 cell cycle phases and for cell survival following treatment with methyl methanesulfonate. However, the naturally occurring human polymorphism in BRCT I supported XRCC1-dependent SSBR and cell survival after DNA alkylation equally well. We conclude that while the BRCT I domain is critical for XRCC1 to maintain genetic integrity and cell survival, the polymorphism does not impact significantly on this function and therefore is unlikely to impact significantly on susceptibility to cancer.


* Corresponding author. Present address: Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RR, United Kingdom. Phone: 01273 678123. Fax: 01273 678121. E-mail: k.w.caldecott{at}sussex.ac.uk.


Molecular and Cellular Biology, April 2002, p. 2556-2563, Vol. 22, No. 8
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.8.2556-2563.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Akulevich, N. M, Saenko, V. A, Rogounovitch, T. I, Drozd, V. M, Lushnikov, E. F, Ivanov, V. K, Mitsutake, N., Kominami, R., Yamashita, S. (2009). Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 16: 491-503 [Abstract] [Full Text]  
  • Levy, N., Oehlmann, M., Delalande, F., Nasheuer, H. P., Van Dorsselaer, A., Schreiber, V., de Murcia, G., Menissier-de Murcia, J., Maiorano, D., Bresson, A. (2009). XRCC1 interacts with the p58 subunit of DNA Pol {alpha}-primase and may coordinate DNA repair and replication during S phase. Nucleic Acids Res 37: 3177-3188 [Abstract] [Full Text]  
  • Kulkarni, A., McNeill, D. R., Gleichmann, M., Mattson, M. P., Wilson, D. M. III (2008). XRCC1 protects against the lethality of induced oxidative DNA damage in nondividing neural cells. Nucleic Acids Res 36: 5111-5121 [Abstract] [Full Text]  
  • Chen, D., Yu, Z., Zhu, Z., Lopez, C. D. (2008). E2F1 Regulates the Base Excision Repair Gene XRCC1 and Promotes DNA Repair. J. Biol. Chem. 283: 15381-15389 [Abstract] [Full Text]  
  • Hoskins, J. M., Marcuello, E., Altes, A., Marsh, S., Maxwell, T., Van Booven, D. J., Pare, L., Culverhouse, R., McLeod, H. L., Baiget, M. (2008). Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes. Clin. Cancer Res. 14: 1788-1796 [Abstract] [Full Text]  
  • Mateuca, R. A., Roelants, M., Iarmarcovai, G., Aka, P. V., Godderis, L., Tremp, A., Bonassi, S., Fenech, M., Berge-Lefranc, J.-L., Kirsch-Volders, M. (2008). hOGG1326, XRCC1399 and XRCC3241 polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23: 35-41 [Abstract] [Full Text]  
  • Huang, W.-Y., Gao, Y.-T., Rashid, A., Sakoda, L. C., Deng, J., Shen, M.-C., Wang, B.-S., Han, T.-Q., Zhang, B.-H., Chen, B. E., Rosenberg, P. S., Chanock, S. J., Hsing, A. W. (2008). Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis 29: 100-105 [Abstract] [Full Text]  
  • Stern, M. C., Conti, D. V., Siegmund, K. D., Corral, R., Yuan, J.-M., Koh, W.-P., Yu, M. C. (2007). DNA Repair Single-Nucleotide Polymorphisms in Colorectal Cancer and their Role as Modifiers of the Effect of Cigarette Smoking and Alcohol in the Singapore Chinese Health Study. Cancer Epidemiol. Biomarkers Prev. 16: 2363-2372 [Abstract] [Full Text]  
  • Berndt, S. I., Huang, W.-Y., Fallin, M. D., Helzlsouer, K. J., Platz, E. A., Weissfeld, J. L., Church, T. R., Welch, R., Chanock, S. J., Hayes, R. B. (2007). Genetic Variation in Base Excision Repair Genes and the Prevalence of Advanced Colorectal Adenoma. Cancer Res. 67: 1395-1404 [Abstract] [Full Text]  
  • Stern, M. C., Siegmund, K. D., Conti, D. V., Corral, R., Haile, R. W. (2006). XRCC1, XRCC3, and XPD Polymorphisms as Modifiers of the Effect of Smoking and Alcohol on Colorectal Adenoma Risk. Cancer Epidemiol. Biomarkers Prev. 15: 2384-2390 [Abstract] [Full Text]  
  • Pachkowski, B. F., Winkel, S., Kubota, Y., Swenberg, J. A., Millikan, R. C., Nakamura, J. (2006). XRCC1 Genotype and Breast Cancer: Functional Studies and Epidemiologic Data Show Interactions between XRCC1 Codon 280 His and Smoking.. Cancer Res. 66: 2860-2868 [Abstract] [Full Text]  
  • Casson, A. G., Zheng, Z., Evans, S. C., Veugelers, P. J., Porter, G. A., Guernsey, D. L. (2005). Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 26: 1536-1541 [Abstract] [Full Text]  
  • Hu, Z., Ma, H., Chen, F., Wei, Q., Shen, H. (2005). XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies. Cancer Epidemiol. Biomarkers Prev. 14: 1810-1818 [Abstract] [Full Text]  
  • Brem, R., Hall, J. (2005). XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res 33: 2512-2520 [Abstract] [Full Text]  
  • Leng, S., Cheng, J., Zhang, L., Niu, Y., Dai, Y., Pan, Z., Li, B., He, F., Zheng, Y. (2005). The Association of XRCC1 Haplotypes and Chromosomal Damage Levels in Peripheral Blood Lymphocyte among Coke-Oven Workers. Cancer Epidemiol. Biomarkers Prev. 14: 1295-1301 [Abstract] [Full Text]  
  • Stern, M. C., Siegmund, K. D., Corral, R., Haile, R. W. (2005). XRCC1 and XRCC3 Polymorphisms and Their Role as Effect Modifiers of Unsaturated Fatty Acids and Antioxidant Intake on Colorectal Adenomas Risk. Cancer Epidemiol. Biomarkers Prev. 14: 609-615 [Abstract] [Full Text]  
  • Shen, J., Gammon, M. D., Terry, M. B., Wang, L., Wang, Q., Zhang, F., Teitelbaum, S. L., Eng, S. M., Sagiv, S. K., Gaudet, M. M., Neugut, A. I., Santella, R. M. (2005). Polymorphisms in XRCC1 Modify the Association between Polycyclic Aromatic Hydrocarbon-DNA Adducts, Cigarette Smoking, Dietary Antioxidants, and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 14: 336-342 [Abstract] [Full Text]  
  • Okano, S., Lan, L., Tomkinson, A. E., Yasui, A. (2005). Translocation of XRCC1 and DNA ligase III{alpha} from centrosomes to chromosomes in response to DNA damage in mitotic human cells. Nucleic Acids Res 33: 422-429 [Abstract] [Full Text]  
  • Fan, J., Otterlei, M., Wong, H.-K., Tomkinson, A. E., Wilson, D. M. III (2004). XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acids Res 32: 2193-2201 [Abstract] [Full Text]  
  • Han, J., Hankinson, S. E., Zhang, S. M., De Vivo, I., Hunter, D. J. (2004). Interaction between Genetic Variations in DNA Repair Genes and Plasma Folate on Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 13: 520-524 [Abstract] [Full Text]  
  • Han, J., Hankinson, S. E., De Vivo, I., Spiegelman, D., Tamimi, R. M., Mohrenweiser, H. W., Colditz, G. A., Hunter, D. J. (2003). A Prospective Study of XRCC1 Haplotypes and Their Interaction with Plasma Carotenoids on Breast Cancer Risk. Cancer Res. 63: 8536-8541 [Abstract] [Full Text]  
  • Moullan, N., Cox, D. G., Angele, S., Romestaing, P., Gerard, J.-P., Hall, J. (2003). Polymorphisms in the DNA Repair Gene XRCC1, Breast Cancer Risk, and Response to Radiotherapy. Cancer Epidemiol. Biomarkers Prev. 12: 1168-1174 [Abstract] [Full Text]  
  • El-Khamisy, S. F., Masutani, M., Suzuki, H., Caldecott, K. W. (2003). A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res 31: 5526-5533 [Abstract] [Full Text]  
  • Nakamura, J., Asakura, S., Hester, S. D., de Murcia, G., Caldecott, K. W., Swenberg, J. A. (2003). Quantitation of intracellular NAD(P)H can monitor an imbalance of DNA single strand break repair in base excision repair deficient cells in real time. Nucleic Acids Res 31: e104-e104 [Abstract] [Full Text]  
  • Okano, S., Lan, L., Caldecott, K. W., Mori, T., Yasui, A. (2003). Spatial and Temporal Cellular Responses to Single-Strand Breaks in Human Cells. Mol. Cell. Biol. 23: 3974-3981 [Abstract] [Full Text]